Menu
Recruiting NCT06029062

tACS for Sensory Motor Recovery After Stroke

No phase Interventional Motor Recovery

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: tACS Sham, tACS 10Hz, tACS 20Hz.
Who it may be relevant to
Registry conditions: Motor Recovery. Basic parameters: 18 years — 75 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

tACS Brain Neuromodulation for Sensory and Motor Recovery After Neurological Impairments

Overview

The overall goal is to investigate the effectiveness of a novel intervention - transcranial alternating current stimulation (tACS) for motor recovery in stroke survivors.

Interventions

  • Device tACS Sham
    Sham tACS will applied to the brain through the scalp for 20 minutes.
  • Device tACS 10Hz
    10Hz tACS will applied to the brain through the scalp for 20 minutes.
  • Device tACS 20Hz
    20Hz tACS will applied to the brain through the scalp for 20 minutes.

Primary outcome measures

  • Block and Box Test (BBT) of Motor functional test [Time frame: Change of BBT performance 5 minutes before and 5 minutes after the tACS intervention will be measured.]
  • EEG alpha band and Beta band [Time frame: Change of EEG alpha band and Beta band 5 minutes before and 5 minutes after the tACS intervention will be measured.]

Eligibility criteria

Inclusion/exclusion criteria for stroke subjects

Inclusion criteria

  • Age between 18\~75 years old
  • ≥ 6 months post stroke, medically stable;
  • Unilateral, single stroke (no restriction on type (ischemic or hemorrhagic) or volume (large or small) of stroke);
  • Visible finger flexor activation/movement
  • The ability to give consent

Exclusion criteria

  • Patients with visual deficit/neglect; hearing or cognitive impairment;
  • Patients that are currently adjusting tone alternating medications (e.g., baclofen), or
  • Patients received botulinum toxin injection to the arm/fingers <4 months, or phenol injections <2 years;
  • Patients with pacemaker, metal implants or supplemental oxygen;
  • Patients who have musculoskeletal disorders, including pain in the affected side
  • Women who are pregnant.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Crossover
Masking
Single blind
Primary purpose
Treatment

Study locations

United States · 1 center
  • The University of Texas Health Science Center — Houston

Identifiers

NCT: NCT06029062 · HSC-MS-22-0046 (Experiment 1)

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗